查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
耶尔森氏菌诊断市场 - 增长、未来展望、竞争分析，2023-2031 年
市场调查报告书
商品编码
1260074

耶尔森氏菌诊断市场 - 增长、未来展望、竞争分析，2023-2031 年

Yersinia Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

耶尔森氏菌是一种革兰氏阳性细菌，可引起末端迴肠炎、肠炎、急性腹泻、肠系膜淋巴结炎和败血症。 耶尔森氏菌是引起胃肠炎和鼠疫的细菌，在儿童中更常见，男性比女性更常见。 此外，据说北美、北欧和斯堪的纳维亚半岛的鼠疫和耶尔森氏菌的流行率很高，使这些地区成为耶尔森氏菌诊断的最大市场。 此外，越来越多地采用和认识新的分子诊断工具也有助于这些市场主导地位。 另一方面，鑑于亚洲新兴国家的大量未开发机会以及日本耶尔森氏菌感染的高流行率，亚太地区的耶尔森氏菌诊断市场潜力巨大。

氨基糖甘类、头孢菌素类、四环素类、甲氧芐氨嘧啶-磺胺甲噁唑 (TMP-SMZ) 和氟奎诺酮类等药物用于治疗耶尔森氏菌感染。 诊断方法包括 ELISA、试管凝集、放射免疫测定、超声、粪便培养、CT 扫描和结肠镜检查。 或者，可以通过对 16S rRNA 基因进行测序来对小肠结肠炎耶尔森菌分离株进行明确检测。 血清学鑑定也可以通过用胞浆菌编码的耶尔森氏菌蛋白进行免疫印迹来进行。 然而，开发适用于直接和间接诊断的更灵敏、高效和方便的快速诊断系统仍然是该市场的挑战。

本报告中回答的关键问题

影响耶尔森氏菌诊断市场增长的关键微观和宏观环境因素有哪些？

现在和预测期内，产品细分和地区的主要投资领域是什么？

到 2031 年的估计和市场预测

在预测期内，哪些细分市场的复合年增长率最快？

哪个细分市场的市场份额更大，为什么？

低收入和中等收入国家是否在投资耶尔森氏菌诊断市场？

按地区划分，最大的耶尔森氏菌诊断市场在哪里？

亚太、拉丁美洲、中东和非洲等新兴市场的市场趋势和动态如何？

推动耶尔森氏菌诊断市场增长的主要趋势是什么？

主要竞争对手及其在全球耶尔森氏菌诊断市场的影响力的关键战略是什么？

内容

第一章前言

  • 报告内容
    • 报告的目的
    • 目标受众
    • 主要产品
  • 市场细分
  • 调查方法
    • 第一阶段 - 二次调查
    • 第二阶段 - 初步调查
    • 第三阶段 - 专家评审
    • 先决条件
    • 采用的方法

第 2 章执行摘要

  • 市场概况：全球耶尔森氏菌诊断市场
  • 全球耶尔森氏菌诊断市场：按 2022 年测试
  • 全球耶尔森氏菌诊断市场：按技术分类，2022 年
  • 全球耶尔森氏菌诊断市场：按地区划分，2022 年
  • 有吸引力的投资建议：按地区划分，2022 年

第 3 章耶尔森氏菌诊断市场：竞争分析

  • 主要供应商的市场定位
  • 供应商采用的策略
  • 主要产业战略
  • 等级分析：2022 年与 2031 年

第 4 章耶尔森氏菌诊断市场：宏观分析和市场动态

  • 介绍
  • 2021-2031 年全球耶尔森氏菌诊断市场价值
  • 市场动态
    • 市场驱动力
    • 市场製约因素
    • 主要问题
    • 主要机会
  • 促进因素和抑制因素的影响分析
  • 跷跷板分析

第 5 章耶尔森氏菌诊断市场：按测试 2021-2031

  • 市场概览
  • 增长和收益分析：2022 年与 2031 年
  • 市场细分
    • 粪便培养
    • ELISA
    • 放射免疫分析
    • 管内聚
    • CT扫描
    • 超声检查
    • 结肠镜检查

第 6 章耶尔森氏菌诊断市场：按技术分类 2021-2031

  • 市场概览
  • 增长和收益分析：2022 年与 2031 年
  • 市场细分
    • DNA探针
    • 免疫测定
    • 单克隆抗体
    • 聚合□链反应
    • 其他

第 7 章北美耶尔森氏菌诊断市场 2021-2031

  • 市场概览
  • 耶尔森氏菌诊断市场：按测试 2021-2031
  • 耶尔森氏菌诊断市场：2021-2031 年（按技术）
  • 耶尔森氏菌诊断市场：地区 2021-2031
    • 北美
      • 美国
      • 加拿大
      • 其他北美地区

第 8 章英国和欧盟耶尔森氏菌诊断市场 2021-2031

  • 市场概览
  • 耶尔森氏菌诊断市场：按测试 2021-2031
  • 耶尔森氏菌诊断市场：2021-2031 年（按技术）
  • 耶尔森氏菌诊断市场：地区 2021-2031
    • 英国和欧盟
      • 英国
      • 德国
      • 西班牙
      • 意大利
      • 法国
      • 其他欧洲地区

第 9 章亚太耶尔森氏菌诊断市场 2021-2031

  • 市场概览
  • 耶尔森氏菌诊断市场：按测试 2021-2031
  • 耶尔森氏菌诊断市场：2021-2031 年（按技术）
  • 耶尔森氏菌诊断市场：地区 2021-2031
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区

第 10 章拉丁美洲耶尔森氏菌诊断市场 2021-2031

  • 市场概览
  • 耶尔森氏菌诊断市场：按测试 2021-2031
  • 耶尔森氏菌诊断市场：2021-2031 年（按技术）
  • 耶尔森氏菌诊断市场：地区 2021-2031
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地区

第 11 章中东和非洲耶尔森氏菌诊断市场 2021-2031

  • 市场概览
  • 耶尔森氏菌诊断市场：按测试 2021-2031
  • 耶尔森氏菌诊断市场：2021-2031 年（按技术）
  • 耶尔森氏菌诊断市场：地区 2021-2031
    • 中东和非洲
      • 海湾合作委员会
      • 非洲
      • 其他中东和非洲地区

第12章公司简介

  • Abbott Laboratories Inc.
  • Affymetrix Inc.
  • Becton Dickinson
  • Bio-Rad Laboratories
  • Danaher Corporation
  • F. Hoffmann La-Roche
  • Gen-probe
  • Hologic
  • Thermo Fisher Scientific
  • 其他公司
Product Code: 137967-01-23

Yersinia is a gram-positive bacteria causing terminal ileitis, enterocolitis, acute diarrhea, mesenteric lymphadenitis, and sepsis. Species of Yersinia cause gastroenteritis and bubonic plague and are often observed in children, and men more than women. Moreover, the prevalence of bubonic plague and yersiniosis is reportedly high in North America, North Europe, and Scandinavian counties, making these regions the largest markets for Yersinia diagnostics. Furthermore, greater adoption of novel molecular diagnostic tools and higher awareness also contribute to the dominance of these markets. On the other hand, the Asia Pacific Yersinia diagnostics market holds great potential due to the wide presence of untapped opportunities in emerging Asian countries and the significantly high prevalence of Yersinia infection in Japan.

Treatment of Yersinia infections includes drugs such as aminoglycosides, cephalosporins, tetracyclines, trimethoprim-sulfamethoxazole (TMP-SMZ), and fluoroquinolones. The diagnostic methods used include ELISA, tube agglutination, radioimmunoassay, ultrasonography, stool culture, CT scan, and colonoscopy. Definite detection of Yersinia enterocolitica isolates can also be performed through sequencing of the 16S rRNA gene. Immunoblot with plasmodial encoded Yersinia protein also enables serological identification. However, developing more sensitive, efficient, and yet simple rapid diagnostic systems that can be applied to direct and indirect diagnosis remains a challenge in this market.

Key players identified for the Yersinia Diagnostics market include but are not limited to:

Abbott Laboratories, Inc., Affymetrix, Inc., Becton Dickinson, Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann La-Roche, Gen-probe, Hologic, Thermo Fisher Scientific, and Other notable players.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Yersinia Diagnostics market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Yersinia Diagnostics market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Test

Stool Culture

ELISA

Radioimmunoassay

Tube Agglutination

CT Scan

Ultrasonography

Colonoscopy

Technology

DNA Probes

Immunoassay

Monoclonal Antibodies

PCR

Others

Region Segment (2021-2031; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Yersinia Diagnostics market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Yersinia Diagnostics market?

Which is the largest regional market for Yersinia Diagnostics market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Yersinia Diagnostics market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Yersinia Diagnostics market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Yersinia Diagnostics Market
  • 2.2. Global Yersinia Diagnostics Market, By Test, 2022 (US$ Million)
  • 2.3. Global Yersinia Diagnostics Market, By Technology, 2022 (US$ Million)
  • 2.4. Global Yersinia Diagnostics Market, By Geography, 2022 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2022

3. Yersinia Diagnostics Market: Competitive Analysis

  • 3.1. Market Positioning of Key Yersinia Diagnostics Market Vendors
  • 3.2. Strategies Adopted by Yersinia Diagnostics Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Yersinia Diagnostics Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Yersinia Diagnostics Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Stool Culture
    • 5.3.2. ELISA
    • 5.3.3. Radioimmunoassay
    • 5.3.4. Tube Agglutination
    • 5.3.5. CT Scan
    • 5.3.6. Ultrasonography
    • 5.3.7. Colonoscopy

6. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. DNA Probes
    • 6.3.2. Immunoassay
    • 6.3.3. Monoclonal Antibodies
    • 6.3.4. PCR
    • 6.3.5. Others

7. North America Yersinia Diagnostics Market, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
  • 7.3. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 7.4.Yersinia Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 7.4.1.1.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 7.4.1.2.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 7.4.1.3.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

8. UK and European Union Yersinia Diagnostics Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
  • 8.3. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 8.4.Yersinia Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.1.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.2.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.3.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.4.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.5.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 8.4.1.6.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

9. Asia Pacific Yersinia Diagnostics Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
  • 9.3. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 9.4.Yersinia Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.1.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.2.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.3.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.4.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.5.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 9.4.1.6.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

10. Latin America Yersinia Diagnostics Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
  • 10.3. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 10.4.Yersinia Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 10.4.1.1.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 10.4.1.2.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 10.4.1.3.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

11. Middle East and Africa Yersinia Diagnostics Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
  • 11.3. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
  • 11.4.Yersinia Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 11.4.1.1.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 11.4.1.2.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Yersinia Diagnostics Market: By Test, 2021-2031, USD (Million)
        • 11.4.1.3.1. Yersinia Diagnostics Market: By Technology, 2021-2031, USD (Million)

12. Company Profile

  • 12.1. Abbott Laboratories, Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Affymetrix, Inc.
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Becton Dickinson
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Bio-Rad Laboratories
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Danaher Corporation
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. F. Hoffmann La-Roche
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Gen-probe
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. Hologic
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Thermo Fisher Scientific
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Other notable players
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 2 Global Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 3 North America Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 4 North America Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 5 U.S. Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 6 U.S. Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 7 Canada Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 8 Canada Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 9 Rest of North America Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 10 Rest of North America Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 11 UK and European Union Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 12 UK and European Union Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 13 UK Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 14 UK Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 15 Germany Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 16 Germany Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 17 Spain Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 18 Spain Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 19 Italy Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 20 Italy Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 21 France Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 22 France Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 23 Rest of Europe Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 24 Rest of Europe Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 25 Asia Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 26 Asia Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 27 China Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 28 China Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 29 Japan Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 30 Japan Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 31 India Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 32 India Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 33 Australia Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 34 Australia Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 35 South Korea Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 36 South Korea Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 37 Latin America Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 38 Latin America Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 39 Brazil Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 40 Brazil Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 41 Mexico Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 42 Mexico Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 43 Rest of Latin America Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 44 Rest of Latin America Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 45 Middle East and Africa Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 46 Middle East and Africa Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 47 GCC Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 48 GCC Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 49 Africa Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 50 Africa Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Yersinia Diagnostics Market By Test, 2021-2031, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Yersinia Diagnostics Market By Technology, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Yersinia Diagnostics Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Yersinia Diagnostics Market: Quality Assurance
  • FIG. 5 Global Yersinia Diagnostics Market, By Test, 2022
  • FIG. 6 Global Yersinia Diagnostics Market, By Technology, 2022
  • FIG. 7 Global Yersinia Diagnostics Market, By Geography, 2022
  • FIG. 8 Market Geographical Opportunity Matrix - Global Yersinia Diagnostics Market, 2022
  • FIG. 9 Market Positioning of Key Yersinia Diagnostics Market Players, 2022
  • FIG. 10 Global Yersinia Diagnostics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 11 Global Yersinia Diagnostics Market, By Test, 2022 Vs 2031, %
  • FIG. 12 Global Yersinia Diagnostics Market, By Technology, 2022 Vs 2031, %
  • FIG. 13 U.S. Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 14 Canada Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 15 Rest of North America Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 16 UK Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 17 Germany Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 18 Spain Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 19 Italy Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 20 France Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 21 Rest of Europe Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 22 China Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 23 Japan Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 24 India Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 25 Australia Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 26 South Korea Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 27 Rest of Asia Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 28 Brazil Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 29 Mexico Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 30 Rest of Latin America Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 31 GCC Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 32 Africa Yersinia Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 33 Rest of Middle East and Africa Yersinia Diagnostics Market (US$ Million), 2021 - 2031